Mainstream Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$152 Buy
+4
New +$184 ﹤0.01% 296

Other funds holding NVO

Mainstream Capital Management's NVO Position: Q3 2026 in Review

Mainstream Capital Management opened a new position in Novo Nordisk (NVO) in Q3 2026: 4 shares worth $152. The stake represents ﹤0.01% of the portfolio and ranks #296 among its holdings.

1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Mainstream Capital Management held 4 shares of Novo Nordisk worth $152 as of Q3 2026.
  • Novo Nordisk was a new Mainstream Capital Management position in Q3 2026.
  • Novo Nordisk made up ﹤0.01% of Mainstream Capital Management's portfolio in Q3 2026, its #296 holding.
  • 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Mainstream Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.